CARL
Carlsmed, Inc. · Healthcare · Health Information Services
Last
$14.48
−$0.08 (−0.58%) 4:00 PM ET
Pre-market $14.57 +$0.09 (+0.65%) 6:52 PM ET
Prev close $14.56
Open $14.87
Day high $15.17
Day low $13.96
Volume 246,174
Avg vol 129,219
Mkt cap
$387.46M
P/E ratio
-2.86
FY Revenue
$41.16M
EPS
-5.07
Gross Margin
74.40%
Sector
Healthcare
AI report sections
CARL
Carlsmed, Inc.
Carlsmed, Inc. operates in a high-margin medical technology niche, but current operations are deeply loss-making with negative free cash flow. Technically, the share price is in the lower half of its 52-week range yet shows short-term upside momentum with price near key moving averages and several bullish breakout signals. Short interest as a percentage of shares outstanding is modest, though the very high short volume ratio on the latest day points to elevated near-term positioning risk.
AI summarized at 10:33 AM ET, 2026-01-12
AI summary scores
INTRADAY: 58 SWING: 63 LONG: 39
Volume vs average
Intraday (cumulative)
+62% (Above avg)
Vol/Avg: 1.62×
RSI
66.06 (Strong)
Strong (60–70)
MACD momentum
Intraday
+0.01 (Strong)
MACD: 0.00 Signal: -0.00
Short-Term
+0.30 (Strong)
MACD: 0.13 Signal: -0.17
Long-Term
+0.23 (Strong)
MACD: -0.29 Signal: -0.53
Intraday trend score 77.13

Latest news

CARL 3 articles Positive: 3 Neutral: 0 Negative: 0
Positive GlobeNewswire Inc. • Carlsmed, Inc.
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

Carlsmed launched its aprevo® Technology Platform for cervical fusion surgeries, featuring AI-driven preoperative planning and 3D-printed patient-specific implants. The platform aims to improve surgical outcomes and precision in spine procedures.

CARL spine surgery AI personalized medicine medical technology cervical fusion
Sentiment note

Company launched innovative medical technology platform, completed first 50+ clinical cases, received positive clinical feedback, and demonstrated potential to transform spine surgery standard of care

Positive GlobeNewswire Inc. • Mike Cordonnier
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

Carlsmed has appointed Jenifer Kamocsay as Chief Legal Officer and Secretary, bringing over two decades of corporate legal experience from life science and technology sectors to strengthen the company's leadership team.

CARL PRGS legal appointment corporate governance spine surgery AI technology
Sentiment note

Company is expanding leadership, strengthening organizational capabilities, and preparing for commercial launch with an experienced legal professional

Positive GlobeNewswire Inc. • Mike Cordonnier
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

Carlsmed, a medical technology company specializing in AI-enabled personalized spine surgery solutions, was added to the Russell 2000 Index following its IPO in July 2025.

CARL AI spine surgery medical technology Russell 2000 Index IPO
Sentiment note

Company achieved significant milestone by being added to Russell 2000 Index, indicating growth potential and market recognition

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal